Recommendation of the President #HPP #48aa – Prevention and early detection of osteoporosis
Recommendation No. 177/2025 of November 21, 2025, of the President of the Agency for Health Technology Assessment and Tariff System on recommended medical technologies, activities carried out under health policy programs, and conditions for the implementation of these programs, concerning the prevention and early detection of osteoporosis
The recommendation is an update of Recommendation No. 9/2020 of November 30, 2020. of the President of the Agency for Health Technology Assessment and Tariff System on recommended medical technologies, activities carried out as part of health policy programs, and the conditions for implementing these programs, concerning the detection of osteoporosis in accordance with Article 48aa(8) of the Act on healthcare services financed from public funds.
The recommendation contains a model solution for a given health problem – Prevention and early detection of osteoporosis.
The recommendation exempts local government units from the obligation to submit a health policy program prepared in accordance with its content for review.
Thus, the recommendation serves as a model for local government units preparing draft programs for this health problem.
The President of the Agency recommends that health policy programs include information and education activities focused on the prevention of osteoporosis and the prevention of osteoporotic fractures and falls in the adult population, training for medical personnel, risk assessment in the population of women aged ≥50 and men aged ≥65, as well as women aged 40-49 and men aged 50-64 with at least one additional risk factor for osteoporotic fractures, DXA bone density testing in individuals with a confirmed risk of serious osteoporotic fractures, and health education for individuals with diagnosed osteoporosis.
The President of the Agency does not recommend the use of other medical technologies and measures in health policy programs, nor conditions of implementation other than those included in this document.
Therefore, from November 21, 2025, in order to prepare a PPZ for the early detection of osteoporosis, the provisions of recommendation No. 177/2025 should be taken into account, and then a statement of compliance of the PPZ project with this recommendation should be sent to the Agency pursuant to Article 48aa(11) of the Act.
There is no need to modify the PPZ currently in force, which entered into force before the publication of Recommendation 177/2025. It is not possible to continue future editions of the PPZ in unchanged form.